Interpharm Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IPAH research report →
About the company
Interpharm Holdings, Inc. specializes in the formulation, manufacturing, and commercialization of generic pharmaceuticals, encompassing both prescription-strength and over-the-counter varieties. The company's medicinal products are supplied to a wide array of clients, including significant retail chains, wholesale distributors, managed healthcare organizations, and nationwide distribution networks.
- CEO
- Raj Sutaria
- IPO
- 2000
- Employees
- 670
- HQ
- Hauppauge, US
Price Chart
- Market Cap
- $660
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -3.23
- Div Yield
- 0.00%
- Gross Margin
- 28.66%
- Op Margin
- -14.21%
- Net Margin
- -18.60%
- ROE
- -82.09%
- ROIC
- -19.23%
- Revenue
- $75.59M · 19.31%
- Net Income
- $-14,058,000 · -270.92%
- EPS
- $-0.26 · -73.33%
- Op Income
- $-10,738,000
- FCF YoY
- -266.51%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -120.16
- Avg Volume
- 7
Get TickerSpark's AI analysis on IPAH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our IPAH coverage
Recent articles, reports, and earnings notes.
No research on IPAH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IPAH report →Similar companies
Peers in the same neighborhood.